Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
124I-Evuzamitide
Locations
1
United States
Oregon Health & Science University
Portland, Oregon, United States
Start Date
January 10, 2023
Primary Completion Date
December 10, 2027
Completion Date
March 10, 2028
Last Updated
April 13, 2026
NCT06355934
NCT06427304
NCT06383143
NCT06672237
NCT06974877
NCT07213297
Lead Sponsor
Oregon Health and Science University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions